OSR Holdings, Inc. (OSRH)

NASDAQ: OSRH · Real-Time Price · USD

0.6620

+0.0400 (6.43%)

At close: Jan 9, 2026, 4:00 PM EST

0.6615

-0.0005 (-0.08%)

After-hours: Jan 9, 2026, 7:59 PM EST

OSR Holdings Employees

As of December 31, 2024, OSR Holdings had 21 total employees, including 19 full-time and 2 part-time employees.

Employees

21

Change

n/a

Growth

n/a

Revenue / Employee

n/a

Profits / Employee

-$314,737

Market Cap

17.00M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	21	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

OSRH News

21 days ago - Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings - PRNewsWire
5 weeks ago - Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target Following Major Licensing Agreement - Newsfile Corp
5 weeks ago - Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months - PRNewsWire
5 weeks ago - OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025 - PRNewsWire
7 weeks ago - Vaximm AG, an OSR Company, Enters Term Sheet With BCM Europe for Potential VXM01 License with $20M Upfront and Up to $815M in Milestones - PRNewsWire
2 months ago - OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology Expansion - PRNewsWire
2 months ago - OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study - PRNewsWire
2 months ago - Emerging Growth Research Initiates Coverage on OSR Holdings, Inc. with a Buy-Emerging Rating and $10.00 Price Target - Newsfile Corp